Article | October 20, 2022

The Case for Augmented Reality for Drug Manufacturers

Source: Apprentice

By: Linas Ozeraitis, Mixed Reality Engineer, Apprentice


‍Augmented reality (AR) integrates digital information with a user’s physical environment.‍ AR works with devices such as tablets, smartphones and head-mounted devices (aka smart glasses), and layers text, videos, photos, holograms, and other media onto a user’s real-world environment. As such, this technology allows users to overlay digital objects onto their field of view, without losing sight of their actual reality.

AR-powered technology allows companies to access and visualize data right in front of their eyes, exactly when they need it. This helps reduce the data burden of CGT, helping to accelerate production in a fraction of the time. This means that personalized medicine isn’t just a pipe dream — powered by the right technology, it’s a reality.

In this article, we’ll explore how COVID and cell and gene therapies have paved the way for AR in pharma.

access the Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.

Subscribe to Pharmaceutical Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Pharmaceutical Online